Pilot Testing of a Behavioral Intervention for Chronic Pain in Individuals With HIV
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02824562|
Recruitment Status : Active, not recruiting
First Posted : July 6, 2016
Last Update Posted : June 9, 2017
|Condition or disease||Intervention/treatment||Phase|
|Chronic Pain||Behavioral: Behavioral intervention for chronic pain in HIV||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||47 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Single (Outcomes Assessor)|
|Official Title:||Development of a Behavioral Intervention for Chronic Pain in Individuals With HIV|
|Study Start Date :||July 2016|
|Actual Primary Completion Date :||June 1, 2017|
|Estimated Study Completion Date :||December 2018|
The intervention group will receive treatment as usual plus a chronic pain self-management program which includes six one-on-one sessions facilitated by a trained interventionist and six group sessions facilitated by a trained interventionist and a peer. A peer is an HIV-infected patient living with chronic pain, who has completed all ten of the one-on-one sessions offered, received training to co-facilitate the six group sessions with the interventionist, and is successfully self-managing his/her chronic pain.
Behavioral: Behavioral intervention for chronic pain in HIV
No Intervention: Control
The control group will receive "treatment as usual". The "treatment as usual" or control group refers to the standard of care that patients receive for their chronic pain. This standard of care allows patients to discuss chronic pain with their providers at their discretion. Although highly variable, providers can recommend and prescribe pharmacologic (e.g., opioid and other pain medication), non-pharmacologic (e.g., physical therapy, referral to psychology) approaches for pain. This study will not interfere in any way with usual care. No additional treatment will be provided to participants allocated to the control group.
- Intervention feasibility: mean number of study intervention sessions attended by participants [ Time Frame: baseline to 6 months ]attendance at intervention sessions will be recorded for each participant. The mean (with range) will be reported.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02824562
|United States, Alabama|
|University of Alabama at Birmingham|
|Birmingham, Alabama, United States, 35233|